Latest filing published 04 Mar 2022 for Syneos Health, Inc., €1.9M.
Filing timeline
BuySaleInsider track record
Alistair Macdonald: trading record in brief
Alistair Macdonald (chief executive) discloses dealings in Syneos Health, Inc. to SEC (Form 4). We count 116 filings; the first trade dates from 30 June 2015 and the latest from 2 March 2022.
Sales make up the whole of the open-market record (51 sales, €26.9M). Other entries cover 39 share grants and 26 option exercises.
The latest filing, published on 4 March 2022, reports a share grant of €1.9M in Syneos Health, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alistair Macdonald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 26,761 shares@ US$80.755.0% of flowClass A Common StockSEC:0001209191-22-016379:3
- 8,209 shares0Class A Common StockSEC:0001209191-22-016379:1
- 8,880 shares0Class A Common StockSEC:0001209191-22-016379:2
- 36,727 shares0Class A Common StockSEC:0001209191-22-016379:0
- 30,498 shares0Class A Common StockSEC:0001209191-22-004114:1
- 15,028 shares@ US$86.0945.4% of flowClass A Common StockSEC:0001209191-22-004114:0
- 10,154 shares@ US$93.6933.5% of flowClass A Common StockSEC:0001209191-22-003086:0
- 35,553 shares@ US$42.763.5% of flowClass A Common StockSEC:0001209191-21-049715:1
- 28,521 shares@ US$87.835.8% of flowClass A Common StockSEC:0001209191-21-049715:2
- 7,032 shares@ US$88.491.4% of flowClass A Common StockSEC:0001209191-21-049715:3
- 4,710 shares@ US$89.9014.3% of flowClass A Common StockSEC:0001209191-21-049715:0
- 4,889 shares@ US$88.201.0% of flowClass A Common StockSEC:0001209191-21-037755:1
- 4,889 shares@ US$42.886.9% of flowClass A Common StockSEC:0001209191-21-037755:0
- 14,039 shares@ US$80.002.6% of flowClass A Common StockSEC:0001209191-21-026373:0
- 17,398 shares@ US$40.121.6% of flowClass A Common StockSEC:0001209191-21-025201:0
- 673 shares@ US$76.110.1% of flowClass A Common StockSEC:0001209191-21-025201:1
- 13,720 shares@ US$77.612.5% of flowClass A Common StockSEC:0001209191-21-025201:2
- 3,005 shares@ US$77.920.5% of flowClass A Common StockSEC:0001209191-21-025201:3
- 7,993 shares0Class A Common StockSEC:0001209191-21-017941:0
- 4,308 shares0Class A Common StockSEC:0001209191-21-017941:1
- 36,429 shares0Class A Common StockSEC:0001209191-21-017941:3
- 14,692 shares@ US$75.503.1% of flowClass A Common StockSEC:0001209191-21-017941:2
- 17,122 shares@ US$75.503.6% of flowClass A Common StockSEC:0001209191-21-017941:4
- 12,450 shares@ US$78.592.2% of flowClass A Common StockSEC:0001209191-21-011937:0
- 13,044 shares@ US$75.172.2% of flowClass A Common StockSEC:0001209191-21-007373:0
25 of 114 declarations
